{
  "nodes": [
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1533",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "Chemotherapy"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1534",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "6 months in first-line treatment"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1536",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "3 months in third-line treatment"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:93",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "anemia"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:92",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "Deregulation of iron metabolism in cancer patients"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:94",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "toxic iron overload"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:95",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "gut microbiota"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "venetoclax with hypomethylating agents"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:585",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "acute myeloid leukemia"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2098",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "elderly patients with acute myeloid leukemia"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2099",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "acute myeloid leukemia patients unfit for standard treatments"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2100",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "0.57"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2101",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "0.52"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2102",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "0.71 in IDH mutation carriers"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2103",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "0.64 in FLT-3 mutation carriers"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2104",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "0.44 in TP53 mutation carriers"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2105",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "neutropenia"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2106",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "thrombocytopenia"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1342",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "cardiac issues"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1341",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "Cancer medications"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:877",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "Cancer and related treatments"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:878",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "body composition"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2637",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "DNA methylation inhibitors"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2638",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "cancer treatment"
      }
    },
    {
      "element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:584",
      "labels": [
        "Entity"
      ],
      "properties": {
        "name": "miR-186-5p"
      }
    }
  ],
  "relationships": [
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1144",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1533",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1534",
      "properties": {
        "type": "achieves median PFS of"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1146",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1533",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1536",
      "properties": {
        "type": "achieves median PFS of"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:70",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:92",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:93",
      "properties": {
        "type": "leads to"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:71",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:92",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:94",
      "properties": {
        "type": "leads to"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:72",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:92",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:95",
      "properties": {
        "type": "affects"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1589",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:93",
      "properties": {
        "type": "causes"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1581",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:585",
      "properties": {
        "type": "treats"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1582",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2098",
      "properties": {
        "type": "shows efficacy in"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1583",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2099",
      "properties": {
        "type": "shows efficacy in"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1584",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2100",
      "properties": {
        "type": "has overall response rate of"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1585",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2101",
      "properties": {
        "type": "has complete remission/complete remission with incomplete marrow recovery rate of"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1586",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2102",
      "properties": {
        "type": "has complete remission/complete remission with incomplete marrow recovery rate of"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1587",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2103",
      "properties": {
        "type": "has complete remission/complete remission with incomplete marrow recovery rate of"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1588",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2104",
      "properties": {
        "type": "has complete remission/complete remission with incomplete marrow recovery rate of"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1590",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2105",
      "properties": {
        "type": "causes"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:1591",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2097",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2106",
      "properties": {
        "type": "causes"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:994",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1341",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:1342",
      "properties": {
        "type": "cause"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:663",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:877",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:878",
      "properties": {
        "type": "impair"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:2027",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2637",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:2638",
      "properties": {
        "type": "are used in"
      }
    },
    {
      "element_id": "5:54096497-a51b-49c1-979f-bc0dbd8f50d3:445",
      "type": "RELATION",
      "start_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:584",
      "end_node_element_id": "4:54096497-a51b-49c1-979f-bc0dbd8f50d3:585",
      "properties": {
        "type": "is diminished in"
      }
    }
  ]
}